Pharmaphorum
Arvinas and Pfizer’s Veppanu is the first PROTAC – and third oral SERD for breast cancer – to be approved by the FDA.
Pharmaphorum
Arvinas and Pfizer's Veppanu is the first PROTAC - and third oral SERD for breast cancer - to be approved by the FDA.
Pharmaphorum
Arvinas and Pfizer’s Veppanu is the first PROTAC – and third oral SERD for breast cancer – to be approved by the FDA.